View of A novel rp- hplc method development & validation for simultaneous estimation of emtricitabine and tenofovir alafenamide in active pharmaceutical ingredients and marketed combined tablet dosage forms

Return to Article Details A novel rp- hplc method development & validation for simultaneous estimation of emtricitabine and tenofovir alafenamide in active pharmaceutical ingredients and marketed combined tablet dosage forms Download Download PDF